Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Grace Grifferty, Hugh Shirley, Jamie McGloin, Jorja Kahn, Adrienne Orriols & Richard Wamai. (2021) Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review. Research and Reports in Tropical Medicine 12, pages 135-151.
Read now
Read now
Amanda Virginia Batista Vieira, Pablo Cantalice Santos Farias, Gilberto Silva Nunes Bezerra, Amanda Tavares Xavier, Manoel Sebastião Da Costa Lima Júnior, Elis Dionísio Da Silva, Walter Lins Barbosa Júnior & Zulma Maria Medeiros. (2021) Evaluation of molecular techniques to visceral leishmaniasis detection in asymptomatic patients: a systematic review. Expert Review of Molecular Diagnostics 21:5, pages 493-504.
Read now
Read now
Articles from other publishers (22)
Muluneh Ademe, Yaneth Osorio, Rawliegh Howe, Saba Atnafu, Tadele Mulaw, Helina Fikre, Bruno L. Travi, Asrat Hailu, Peter C. Melby & Tamrat Abebe. (2023) Hematological and Clinical Features Associated with Initial Poor Treatment Outcomes in Visceral Leishmaniasis Patients with and without HIV Coinfection in Gondar, Northwest Ethiopia. Tropical Medicine and Infectious Disease 8:1, pages 36.
Crossref
Crossref
Haruna Luz Barazorda-Ccahuana, Luis Daniel Goyzueta-Mamani, Mayron Antonio Candia Puma, Camila Simões de Freitas, Grasiele de Sousa Vieria Tavares, Daniela Pagliara Lage, Eduardo Antonio Ferraz Coelho & Miguel Angel Chávez-Fumagalli. (2023) Computer-aided drug design approaches applied to screen natural product’s structural analogs targeting arginase in Leishmania spp. F1000Research 12, pages 93.
Crossref
Crossref
Isha Saini, Jyoti Joshi & Sukhbir Kaur. (2022) Unwelcome prevalence of leishmaniasis with several other infectious diseases. International Immunopharmacology 110, pages 109059.
Crossref
Crossref
Amel Bekkar, Nathalie Isorce, Tiia Snäkä, Stéphanie Claudinot, Chantal Desponds, Dmitry Kopelyanskiy, Florence Prével, Marta Reverte, Ioannis Xenarios, Nicolas Fasel & Filipa Teixeira. (2022) Dissection of the macrophage response towards infection by the Leishmania-viral endosymbiont duo and dynamics of the type I interferon response. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Angela M. A. Velásquez, Paula J. Bartlett, Irwin A. P. Linares, Thais G. Passalacqua, Daphne D. L. Teodoro, Kely B. Imamura, Stela Virgilio, Luiz R. O. Tosi, Aline de Lima Leite, Marilia A. R. Buzalaf, Jecika M. Velasques, Adelino V. G. Netto, Andrew P. Thomas & Marcia A. S. Graminha. (2022)
New Insights into the Mechanism of Action of the Cyclopalladated Complex (CP2) in
Leishmania
: Calcium Dysregulation, Mitochondrial Dysfunction, and Cell Death
. Antimicrobial Agents and Chemotherapy 66:1.
Crossref
Crossref
Kishor Pandey, Anup Bastola, Gong Haiyan, Uttam Raj Pyakurel, Basu Dev Pandey & Shyam Prakash Dumre. (2021) Emergence of cutaneous leishmaniasis in Nepal. Tropical Medicine and Health 49:1.
Crossref
Crossref
Hermali Silva, Achala Liyanage, Theja Deerasinghe, Vasana Chandrasekara, Kalaivani Chellappan & Nadira D. Karunaweera. (2021) Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination. PLOS ONE 16:10, pages e0259009.
Crossref
Crossref
Evanthia Chazapi, George E. Magoulas, Kyriakos C. Prousis & Theodora Calogeropoulou. (2021) Phospholipid Analogues as Chemotherapeutic Agents Against Trypanosomatids. Current Pharmaceutical Design 27:15, pages 1790-1806.
Crossref
Crossref
Michel Bengtson, Mitasha Bharadwaj, Astrid ten Bosch, Hellen Nyakundi, Damaris Matoke-Muhia, Cees Dekker & Jan-Carel Diehl. (2020) Matching Development of Point-of-Care Diagnostic Tests to the Local Context: A Case Study of Visceral Leishmaniasis in Kenya and Uganda. Global Health: Science and Practice 8:3, pages 549-565.
Crossref
Crossref
Shivani Thakur, Jyoti Joshi & Sukhbir Kaur. (2020) Leishmaniasis diagnosis: an update on the use of parasitological, immunological and molecular methods. Journal of Parasitic Diseases 44:2, pages 253-272.
Crossref
Crossref
Ritika Kabra, Prajakta Ingale & Shailza Singh. (2020)
Computationally designed synthetic peptides for transporter proteins imparts allostericity in Miltefosine resistant
L. major
. Biochemical Journal 477:10, pages 2007-2026.
Crossref
Crossref
Walter Lins Barbosa Júnior, Alda Maria Justo, Ana Maria Aguiar dos Santos, Rodrigo Feliciano do Carmo, Fábio Lopes de Melo, Luydson Richardson Silva Vasconcelos & Zulma Maria de Medeiros. (2020) SLC11A1 (rs3731865) polymorphism and susceptibility to visceral leishmaniasis in HIV-coinfected patients from Northeastern Brazil. Parasitology Research 119:2, pages 491-499.
Crossref
Crossref
Maiara Maria Romanelli, Thais Alves da Costa-Silva, Edezio Cunha-Junior, Daiane Dias Ferreira, Juliana M. Guerra, Andres Jimenez GalisteoJr.Jr., Erika Gracielle Pinto, Leandro R. S. Barbosa, Eduardo Caio Torres-Santos & Andre Gustavo Tempone. (2019) Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Crossref
Rosa M. Reguera, Yolanda Pérez-Pertejo, Camino Gutiérrez-Corbo, Bárbara Domínguez-Asenjo, César Ordóñez, Carlos García-Estrada, María Martínez-Valladares & Rafael Balaña-Fouce. (2019) Current and promising novel drug candidates against visceral leishmaniasis. Pure and Applied Chemistry 91:8, pages 1385-1404.
Crossref
Crossref
Karina M. Rebello, Valter V. Andrade-Neto, Claudia Regina B. Gomes, Marcos Vinícius N. de Souza, Marta H. Branquinha, André L. S. Santos, Eduardo Caio Torres-Santos & Claudia M. d'Avila-Levy. (2019) Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Crossref
Gilberto Silva Nunes Bezerra, Walter Lins BarbosaJúniorJúnior, Elis Dionísio da Silva, Nilma Cintra Leal & Zulma Maria de Medeiros. (2019) Urine as a promising sample for Leishmania DNA extraction in the diagnosis of visceral leishmaniasis – a review. The Brazilian Journal of Infectious Diseases 23:2, pages 111-120.
Crossref
Crossref
Lais Pereira, Fabiano Oliveira, Shannon Townsend, Sonia Metangmo, Claudio Meneses, Ian N. Moore, Claudia I. Brodskyn, Jesus G. Valenzuela, Stefan Magez & Shaden Kamhawi. (2018) Coinfection With Trypanosoma brucei Confers Protection Against Cutaneous Leishmaniasis. Frontiers in Immunology 9.
Crossref
Crossref
Iolanda Graepp Fontoura, David Soeiro Barbosa, Antonio Marcus de Andrade Paes, Floriacy Stabnow Santos, Marcelino Santos Neto, Volmar Morais Fontoura, Jackson Mauricio Lopes Costa & Ana Lúcia Abreu Silva. (2018)
Epidemiological, clinical and laboratory aspects of human visceral leishmaniasis (HVL) associated with human immunodeficiency virus (HIV) coinfection: a
systematic review
. Parasitology 145:14, pages 1801-1818.
Crossref
Crossref
Eltahir Awad Gasim Khalil. 2018. Leishmaniases as Re-emerging Diseases. Leishmaniases as Re-emerging Diseases.
Chiara Borsari, Antonio Quotadamo, Stefania Ferrari, Alberto Venturelli, Anabela Cordeiro-da-Silva, Nuno Santarem & Maria Paola Costi. 2018. Neglected Diseases: Extensive Space for Modern Drug Discovery. Neglected Diseases: Extensive Space for Modern Drug Discovery
39
95
.
Abdelhak Neghra, Marylin Lecsö, Marie-José Butel, Laila S. Espindola, Brigitte Deguin & Elisabeth Seguin. (2017) Amidochromenes for Promising Antileishmanial Activity. Natural Product Communications 12:9, pages 1934578X1701200.
Crossref
Crossref
Tharaka Wijerathna, Nayana Gunathilaka, Kithsiri Gunawardana & Wasana Rodrigo. (2017) Potential Challenges of Controlling Leishmaniasis in Sri Lanka at a Disease Outbreak. BioMed Research International 2017, pages 1-9.
Crossref
Crossref